Table: Fuji Pharmaceutical -2020/21 parent results

Fuji Pharma

05/11/2021 08:00

Nov 5 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Sep 30, 2021    Sep 30, 2020   Sep 30, 2022     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           31.86           31.26          33.51        16.28    
               (+1.9 pct)      (-7.3 pct)     (+9.8 pct)    (+6.0 pct) 
  Operating        3.37            2.90           3.44         1.59    
               (+16.1 pct)     (-24.5 pct)    (+1.8 pct)   (-39.6 pct) 
  Recurring        3.32            2.81           3.49         1.62    
               (+18.2 pct)     (-29.2 pct)    (+5.0 pct)   (-40.5 pct) 
  Net              2.55            2.02           2.56         1.19    
               (+26.7 pct)     (-29.1 pct)    (+0.3 pct)   (-41.1 pct) 
  EPS           95.10 yen       64.70 yen     105.49 yen    48.87 yen  
  Ann Div       29.00 yen       29.00 yen      32.00 yen               
  -Q2 Div       14.00 yen       14.00 yen      15.00 yen               
  -Q4 Div       15.00 yen       15.00 yen      17.00 yen               
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T